Efficacy, durability, and safety of faricimab with extended dosing up to every 16 weeks in Japanese patients with diabetic macular edema: 1-year results from the Japan subgroup of the phase 3 YOSEMITE trial

Masahiko Shimura, Shigehiko Kitano, Nahoko Ogata, Yoshinori Mitamura, Hideyasu Oh, Haruka Ochi, Shino Ohsawa, Akito Hirakata, on behalf of the YOSEMITE and RHINE Investigators, Matthias Bolz, Oliver Findl, Andreas Pollreisz, Martin Weger, Vesselin Daskalov, Aneta Misheva, Iva Petkova, Daniela Tosheva Guneva, Petja Vassileva, Pierre Loïc Cornut, Jean François Korobelnik, O. Lebreton, Ramin Tadayoni, Nicole Eter, Nicolas Feltgen, Carsten Framme, Katrin Lorenz, Georg Spital, György Bátor, András Seres, Lajos Szalczer, Edit Tóth‐Molnár, Attila Vajas, Balázs Varsányi, Michaella Goldstein, Jaime Levy, Haia Morori-Katz, Irit Rosenblatt, Yoreh Barak, Francesco Bandello, Carlo Cagini, Leonardo Mastropasqua, Massimo Nicolò, Maria Cristina Parravano, Francesco Viola, Akira Fukutomi, Ken Hayashi, Akito Hirakata, Shigeru Honda, Yasuhiro Ikeda, Yasuki Ito, Tsutomu Kawasaki, Kazuhiro Kimura, Genichiro Kishino, Shigehiko Kitano, Takatoshi Maeno, Yoshinori Mitamura, Tomoaki Murakami, Kousuke Noda, Akira Obana, Nahoko Ogata, Hideyasu Oh, Osamu Sawada, Akito Shimouchi, Masahiko Shimura, Masahiko Sugimoto, Iichiro Sugita, Hitoshi Takagi, Kei Takayama, Teruyo Tanabe, Tsutomu Yasukawa, Shigeo Yoshida, Renata Cunha Matheus Rodrigues Garcia, David Lozano Rechy, Virgilio Morales Cantón, Juan Ramirez Estudillo, Karen Barraza, Carlos Fernandez, Miguel A. Guzmán, Silvio Lujan, Maciej Gawęcki, Ewa Herba, Katarzyna Michalska‐Małecka, Maria Muzyka−Woźniak, Kamila Nester-Ostrowska, Piotr Oleksy, Bogumił Wowra, Edward Wylęgała, M V Budzinskaya, Alexey N. Kulikov, Т. В. Моругова, Maria Hurcikova, Marek Káčerik, Blandína Lipková, Santiago Abengoechea, Alfredo Adan Civera, Pedro Amat, Francisco Cabrera, Carlos Eduardo Cava, Alfredo García‐Layana, Francisco Gomez Ulla